Altasciences, a leading contract research organisation (CRO), is headquartered in California and operates across North America and Europe. Founded in 2015, the company has rapidly established itself in the pharmaceutical and biotechnology sectors, specialising in early-phase clinical trials and laboratory services. With a focus on providing integrated solutions, Altasciences offers a unique combination of clinical development and laboratory services, ensuring streamlined processes for clients. The company is recognised for its commitment to quality and efficiency, which has positioned it as a trusted partner in drug development. Notable achievements include a robust portfolio of successful studies and a growing reputation for innovation in clinical research. Altasciences continues to enhance its market position by delivering tailored services that meet the evolving needs of the industry.
How does Altasciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Altasciences's score of 28 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
As of the latest available data, Altasciences, headquartered in Canada, has not reported any specific carbon emissions figures. However, the company is committed to achieving net-zero emissions across all scopes by 2050, as indicated by their Science Based Targets initiative (SBTi) commitments. This long-term target reflects Altasciences's dedication to addressing climate change within the pharmaceuticals, biotechnology, and life sciences sector. The company has established a framework for its climate commitments, with a focus on reducing emissions in alignment with industry standards. Although no specific reduction targets or achievements have been disclosed, Altasciences's commitment to net-zero emissions demonstrates a proactive approach to sustainability and environmental responsibility. Altasciences's climate strategy is not cascaded from a parent company, indicating that their commitments and initiatives are independently developed. The company is actively working towards integrating sustainable practices into its operations, contributing to a broader effort within the industry to mitigate climate impact.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Altasciences has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
